NEW YORK (Reuters) - The U.S. Food and Drug Administration said on Tuesday it will allow regulators in eight European countries to determine whether drug manufacturing facilities there meet FDA requirements, freeing up American inspectors to spend more time in higher-risk countries like India and China.
No comments:
Post a Comment